Literature DB >> 24333060

Glucose buffer is suitable for blood group conversion with α-N acetylgalactosaminidase and α-galactosidase.

Hong-Wei Gao1, Su-Bo Li1, Guo-Qiang Bao1, Xue Zhang1, Hui Li2, Ying-Li Wang1, Ying-Xia Tan1, Shou-Ping Ji1, Feng Gong1.   

Abstract

BACKGROUND: It is well known that the buffer plays a key role in the enzymatic reaction involved in blood group conversion. In previous study, we showed that a glycine buffer is suitable for A to O or B to O blood group conversion. In this study, we investigated the use of 5% glucose and other buffers for A to O or B to O blood group conversion by α-N-acetylgalactosaminidase or α-galactosidase.
MATERIALS AND METHODS: We compared the binding ability of α-N-acetylgalactosaminidase/α-galactosidase with red blood cells (RBC) in different reaction buffers, such as normal saline, phosphate-buffered saline (PBS), a disodium hydrogen phosphate-based buffer (PCS), and 5% commercial glucose solution. The doses of enzymes necessary for the A/B to O conversion in different reaction buffers were determined and compared. The enzymes' ability to bind to RBC was evaluated by western blotting, and routine blood typing and fluorescence activated cell sorting was used to evaluate B/A to O conversion efficiency.
RESULTS: The A to O conversion efficiency in glucose buffer was similar to that in glycine buffer with the same dose (>0.06 mg/mL pRBC). B to O conversion efficiency in glucose buffer was also similar to that in glycine buffer with the same dose (>0.005 mg/mL pRBC). Most enzymes could bind with RBC in glycine or glucose buffer, but few enzymes could bind with RBC in PBS, PCS, or normal saline.
CONCLUSION: These results indicate that 5% glucose solution provides a suitable condition for enzymolysis, especially for enzymes combining with RBC. Meanwhile, the conversion efficiency of A/B to O was similar in glucose buffer and glycine buffer. Moreover, 5% glucose solution has been used for years in venous transfusion, it is safe for humans and its cost is lower. Our results do, therefore, suggest that 5% glucose solution could become a novel suitable buffer for A/B to O blood group conversion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24333060      PMCID: PMC3926730          DOI: 10.2450/2013.0023-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  8 in total

1.  Bacterial glycosidases for the production of universal red blood cells.

Authors:  Qiyong P Liu; Gerlind Sulzenbacher; Huaiping Yuan; Eric P Bennett; Greg Pietz; Kristen Saunders; Jean Spence; Edward Nudelman; Steven B Levery; Thayer White; John M Neveu; William S Lane; Yves Bourne; Martin L Olsson; Bernard Henrissat; Henrik Clausen
Journal:  Nat Biotechnol       Date:  2007-04-01       Impact factor: 54.908

2.  [A reconstructed B. Fragilis-derived recombinant α-galactosidase developed for human blood type B→O conversion].

Authors:  Hong-Wei Gao; Su-Bo Li; Guo-Qiang Bao; Ying-Xia Tan; Ling-Yan Wang; Si-Hu Jin; Ying-Li Wang; Shou-Ping Ji; Feng Gong
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2011-04

3.  Purification and characterization of blood group A-degrading isoforms of alpha-N-acetylgalactosaminidase from Ruminococcus torques strain IX-70.

Authors:  L C Hoskins; E T Boulding; G Larson
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

4.  Application of α-N-acetylgalactosaminidase and α-galactosidase in AB to O red blood cells conversion.

Authors:  Hongwei Gao; Subo Li; Yingxia Tan; Shouping Ji; Yingli Wang; Guoqiang Bao; Lijuan Xu; Feng Gong
Journal:  Artif Cells Nanomed Biotechnol       Date:  2012-10-02       Impact factor: 5.678

5.  Identification of a GH110 subfamily of alpha 1,3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen.

Authors:  Qiyong P Liu; Huaiping Yuan; Eric P Bennett; Steven B Levery; Edward Nudelman; Jean Spence; Greg Pietz; Kristen Saunders; Thayer White; Martin L Olsson; Bernard Henrissat; Gerlind Sulzenbacher; Henrik Clausen
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

6.  Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals.

Authors:  J Goldstein; G Siviglia; R Hurst; L Lenny; L Reich
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

7.  [Removal of αGal xenotransplantation antigen by a novel α-galactosidase].

Authors:  Hong-Wei Gao; Xue Zhang; Su-Bo Li; Ying-Xia Tan; Guo-Qiang Bao; Ying-Li Wang; Li-Juan Xu; Shou-Ping Ji; Feng Gong
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2012-10

8.  Characterization of recombinant alpha-galactosidase for use in seroconversion from blood group B to O of human erythrocytes.

Authors:  A Zhu; L Leng; C Monahan; Z Zhang; R Hurst; L Lenny; J Goldstein
Journal:  Arch Biochem Biophys       Date:  1996-03-15       Impact factor: 4.013

  8 in total
  1 in total

Review 1.  Toward universal donor blood: Enzymatic conversion of A and B to O type.

Authors:  Peter Rahfeld; Stephen G Withers
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.